Dissection-independent production of Plasmodium sporozoites from whole mosquitoes
© 2021 Blight et al..
Progress towards a protective vaccine against malaria remains slow. To date, only limited protection has been routinely achieved following immunisation with either whole-parasite (sporozoite) or subunit-based vaccines. One major roadblock to vaccine progress, and to pre-erythrocytic parasite biology in general, is the continued reliance on manual salivary gland dissection for sporozoite isolation from infected mosquitoes. Here, we report development of a multi-step method, based on batch processing of homogenised whole mosquitoes, slurry, and density-gradient filtration, which combined with free-flow electrophoresis rapidly produces a pure, infective sporozoite inoculum. Human-infective Plasmodium falciparum and rodent-infective Plasmodium berghei sporozoites produced in this way are two- to threefold more infective than salivary gland dissection sporozoites in in vitro hepatocyte infection assays. In an in vivo rodent malaria model, the same P. berghei sporozoites confer sterile protection from mosquito-bite challenge when immunisation is delivered intravenously or 60-70% protection when delivered intramuscularly. By improving purity, infectivity, and immunogenicity, this method represents a key advancement in capacity to produce research-grade sporozoites, which should impact delivery of a whole-parasite based malaria vaccine at scale in the future.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:4 |
---|---|
Enthalten in: |
Life science alliance - 4(2021), 7 vom: 07. Juli |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Blight, Joshua [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 05.01.2022 Date Revised 21.02.2024 published: Electronic-Print SWISSPROT: P06915 Citation Status MEDLINE |
---|
doi: |
10.26508/lsa.202101094 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM326826963 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM326826963 | ||
003 | DE-627 | ||
005 | 20240222091113.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.26508/lsa.202101094 |2 doi | |
028 | 5 | 2 | |a pubmed24n1301.xml |
035 | |a (DE-627)NLM326826963 | ||
035 | |a (NLM)34135099 | ||
035 | |a (PII)e202101094 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Blight, Joshua |e verfasserin |4 aut | |
245 | 1 | 0 | |a Dissection-independent production of Plasmodium sporozoites from whole mosquitoes |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.01.2022 | ||
500 | |a Date Revised 21.02.2024 | ||
500 | |a published: Electronic-Print | ||
500 | |a SWISSPROT: P06915 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021 Blight et al. | ||
520 | |a Progress towards a protective vaccine against malaria remains slow. To date, only limited protection has been routinely achieved following immunisation with either whole-parasite (sporozoite) or subunit-based vaccines. One major roadblock to vaccine progress, and to pre-erythrocytic parasite biology in general, is the continued reliance on manual salivary gland dissection for sporozoite isolation from infected mosquitoes. Here, we report development of a multi-step method, based on batch processing of homogenised whole mosquitoes, slurry, and density-gradient filtration, which combined with free-flow electrophoresis rapidly produces a pure, infective sporozoite inoculum. Human-infective Plasmodium falciparum and rodent-infective Plasmodium berghei sporozoites produced in this way are two- to threefold more infective than salivary gland dissection sporozoites in in vitro hepatocyte infection assays. In an in vivo rodent malaria model, the same P. berghei sporozoites confer sterile protection from mosquito-bite challenge when immunisation is delivered intravenously or 60-70% protection when delivered intramuscularly. By improving purity, infectivity, and immunogenicity, this method represents a key advancement in capacity to produce research-grade sporozoites, which should impact delivery of a whole-parasite based malaria vaccine at scale in the future | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
700 | 1 | |a Sala, Katarzyna A |e verfasserin |4 aut | |
700 | 1 | |a Atcheson, Erwan |e verfasserin |4 aut | |
700 | 1 | |a Kramer, Holger |e verfasserin |4 aut | |
700 | 1 | |a El-Turabi, Aadil |e verfasserin |4 aut | |
700 | 1 | |a Real, Eliana |e verfasserin |4 aut | |
700 | 1 | |a Dahalan, Farah A |e verfasserin |4 aut | |
700 | 1 | |a Bettencourt, Paulo |e verfasserin |4 aut | |
700 | 1 | |a Dickinson-Craig, Emma |e verfasserin |4 aut | |
700 | 1 | |a Alves, Eduardo |e verfasserin |4 aut | |
700 | 1 | |a Salman, Ahmed M |e verfasserin |4 aut | |
700 | 1 | |a Janse, Chris J |e verfasserin |4 aut | |
700 | 1 | |a Ashcroft, Frances M |e verfasserin |4 aut | |
700 | 1 | |a Hill, Adrian Vs |e verfasserin |4 aut | |
700 | 1 | |a Reyes-Sandoval, Arturo |e verfasserin |4 aut | |
700 | 1 | |a Blagborough, Andrew M |e verfasserin |4 aut | |
700 | 1 | |a Baum, Jake |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Life science alliance |d 2018 |g 4(2021), 7 vom: 07. Juli |w (DE-627)NLM286067536 |x 2575-1077 |7 nnns |
773 | 1 | 8 | |g volume:4 |g year:2021 |g number:7 |g day:07 |g month:07 |
856 | 4 | 0 | |u http://dx.doi.org/10.26508/lsa.202101094 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 4 |j 2021 |e 7 |b 07 |c 07 |